Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2024-05-10 2024-05-10
Drug Identification Number 02234504 02234504
Brand name APO-TERAZOSIN APO-TERAZOSIN
Common or Proper name TERAZOSIN TERAZOSIN
Company Name APOTEX INC APOTEX INC
Ingredients TERAZOSIN TERAZOSIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code G04CA G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-09 2024-04-09
Estimated end date 2024-05-17 2024-05-17
Actual end date 2024-05-09 2024-05-09
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments